CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 34 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-16 | Dalal Anupam Director | Grant or award · Stock Option (Right to buy) | +12,500 | 12,500 | ||
| 2016-06-16 | Clayman Michael D. Director | Grant or award · Stock Option (Right to buy) | +12,500 | 12,500 | ||
| 2016-04-04 | Hadas Nicole R. SVP, General Counsel, Sec. | Sale | −1,556 | $9.41 | $15K | 85,528 |
| 2016-04-04 | Dahan Michel SVP, Chief Business Officer | Sale | −1,401 | $9.41 | $13K | 74,956 |
| 2016-02-22 | Maroni Bradley SVP and Chief Medical Officer | Grant or award | +36,500 | 38,859 | ||
| 2016-02-22 | Maroni Bradley SVP and Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +55,850 | 55,850 | ||
| 2016-02-22 | Hadas Nicole R. SVP, General Counsel, Sec. | Grant or award | +22,500 | 87,084 | ||
| 2016-02-22 | Hadas Nicole R. SVP, General Counsel, Sec. | Grant or award · Stock Option (Right to Buy) | +34,300 | 34,300 | ||
| 2016-02-22 | Butler John P. CEO and President | Grant or award | +125,500 | 351,173 | ||
| 2016-02-22 | Butler John P. CEO and President | Grant or award · Stock Option (Right to Buy) | −190,550 | 190,550 | ||
| 2016-02-22 | Amello Jason SVP, CFO & Treasurer | Grant or award | +26,000 | 33,330 | ||
| 2016-02-22 | Amello Jason SVP, CFO & Treasurer | Grant or award · Stock Option (Right to Buy) | +39,650 | 39,650 | ||
| 2016-01-15 | Butler John P. CEO and President | Option exercise | +25,000 | $0.47 | $12K | 225,673 |
| 2016-01-15 | Butler John P. CEO and President | Option exercise · Stock Option (Right to Buy) | −25,000 | 407,000 | ||
| 2016-01-04 | Hadas Nicole R. SVP, General Counsel, Sec. | Sale | −1,811 | $12.28 | $22K | 64,584 |
| 2015-10-02 | Nash Duane Director | Sale | −996 | $8.65 | $9K | 31,609 |
| 2015-10-02 | Hadas Nicole R. SVP, General Counsel, Sec. | Sale | −1,484 | $8.67 | $13K | 65,260 |
| 2015-07-02 | Nash Duane Director | Sale | −996 | $9.53 | $9K | 32,605 |
| 2015-07-02 | Hadas Nicole R. SVP, General Counsel, Sec. | Sale | −1,484 | $9.54 | $14K | 66,744 |
| 2015-06-10 | Clayman Michael D. Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 |
Page 25 of 27 · 537 trades